The systolic time intervals of the left ventricle in 30 patients with ischemic heart disease but without heart failure were compared with those of 30 normal individuals before and after inhalation of amyl nitrite by using polygraphic recordings.
T HE AMYL NITRITE (AN) inhalation test has been widely used for differentiation of various heart murmurs. Lately it has been applied to an evaluation of the diastolic heart sounds in normal subjects and patients with ischemic heart disease.' As a result, characteristic differences in the sound amplitude changes following inhalation have been demonstrated in the two groups.
The potential usefulness of systolic time intervals as measures of the left ventricular performances in normal individuals and in patients with heart disease has been shown in recent years.2-'3 Although the systolic intervals, such as the ejection time and the preejection period, of patients with decompensated heart disease are different from those of normal subjects,2 3 these parameters may not separate patients with compensated heart disease from normal persons in either the resting condition8 14 or during exercise. 10 Since it is easily applied and quickly active on the cardiovascular system, amyl nitrite was employed in the present study in order to determine whether differences in the systolic intervals of normal individuals and patients with compensated ischemic heart disease might be brought out under conditions of circulatory stress induced by the drug.
Methods
Observations were made in 30 normal male subjects who varied in age from 35 to 59 years (average, 45.3 years) and in an equal number of male patients with ischemic heart disease (IHD), varying in age from 39 to 58 years (average, 47.0). Normal subjects were those whose history, physical examination, chest roentgenograms, and electrocardiograms revealed no evidence of heart disease. Each patient had a clinical diagnosis of IHD with a functional capacity of I or II by the New York Heart Association classification and showed definite S-T segment depression in leads of the resting electrocardiogram reflecting the left ventricular potential. Patients who had the following abnormalities were carefully excluded from this study: congestive heart failure, significant heart murmur, hypertension, conduction defect, or arrhythmia in the electrocardiogram.
In conjunction with this study, a similar observation was made in Japan using Japanese subjects. In Japan, the selection of subjects and the experimental protocol were the same as in this study. Thirty normal Japanese males (mean age,
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Normal Subjects 45.8 years) and 25 Japanese male patients with compensated IHD (mean age, 46.0 years) were selected.
All studies were carried out with the subjects in the supine position and in a basal, postabsorptive state. In each subject, simultaneous recordings of the high-frequency phonocardiogram, electrocardiogram (lead II), and the indirect carotid pulse were made on a multichannel, photographic recording unit (Sanborn 564 series) at a paper speed of 100 mm/sec with time markers indicating 0.04 sec. Heart sounds were recorded over the upper part of the precordium with a contact microphone (Sanbom). The indirect carotid pulse was obtained with a standard, funnel-shaped pick-up connected to a Sanborn Model 374 transducer. In the Japanese study, the same methods were employed except that a different type of multichannel recorder (San-ei mingograph) was used.
Shortly after the control tracing was made, amyl nitrite was inhaled for 15 sec from a broken ampule held under the nostrils. The subsequent tracings were taken at 15-sec intervals during 2 minutes following the start of inhalation. Each recording was done during end-expiratory apnea Abbreviations: Change = deviations from the control values; QS2 = total electromechanical interval; ET = ejection time; PEP = pre-ejection period; I = index. Number after ±+i is standard deviation.
*tt Statistically significant differences (compared to the control period): * = P < 0.01; t = P < 0.05 and I = P = 0.05. cardiovascular hemodynamics. All patients had QRS intervals of 0.10 sec or less and were in sinus rhythm at the time of the study.
Measurements
The following intervals of the left ventricular systolic cycle were measured: The total electromechanical interval (Q-S2) was measured from the onset of the QRS complex to the initial high-Influence of Amyl Nitrite on the Heart Rate, Various with Compensated Ischemic Heart Disease frequency vibration of the aortic component of the second heart sound; the ejection time (ET), from the beginning of the upstroke to the trough of the incisura of the carotid arterial pulse tracing; and the pre-ejection period (PEP) was derived by subtracting the ejection time from the QS2 interval. All intervals were calculated from the average of measurements made on 5 to Abbreviations: Refer to table 1. IHD = ischemic heart disease; P = statistical significance of difference between the two groups in each period; NS = not significant.
Circulation, Volume XL, September 1969 Indices of these three intervals were also derived according to the formulae of Weissler and associates3: QS2 index (QS2I) = QS2 + 2.1 HR msec; ET index (ETI) ET + 1.7 HR msec; and PEP index (PEPI) PEP + 0.4 HR msec. Finally, the ratio of ET to PEP was calculated as suggested by others.8 15 Heart rate (HR) was derived from the average R-R interval. In the Japanese study only, blood pressure (BP) was measured from the left upper extremity with a standard cuff method. These parameters were obtained from each tracing for each period. Then, the mean values, the standard deviations of the mean, and the absolute changes from the control values were computed for each of the two studied groups (tables 1 to 3). The statistical significance of the differences (P values) between the two groups in each postinhalation period was calculated with the Student t-test (figs. 1 to 3).
In three American and two Japanese subjects The changes in the HR, QS2, ET, and PEP following inhalation of amyl nitrite in the normal subjects (open circles) and in the patients with IHD (closed circles), and the statistical significances of the differences between the two groups in each period. For The changes in the QS2I, ETI, PEPI, and ETIPEP following inhalation of amyl nitrite in the normd subjects (open circles) and in the patients with IHD (closed circles), and the statistical significances of the differences between the two groups in each period. For abbreviations refer to table 1 and figure 1. 6. PEP: Decreased by 31 msec (P < 0.01). 7. PEPI: Decreased by 21 msec (P < 0.01). 8. ET/PEP: Increased by 1.31 (P < 0.01).
In the normal subjects, inhalation of amyl nitrite resulted in a statistically significant increase in the HR, QS2L, ETI, and ET/PEP, a significant decrease in the QS2, PEP, and PEPI, and an insignificant decrease in the ET.
The Ischemic Heart Disease (IHD) Group (Table 2) 1. HR: Increased by 32 (P <0.01). 2. QS2: Decreased by 72 msec (P <0.01). 3. QS2I: Decreased by 15 msec (P > 0.05).
ET:
Decreased by 51 msec (P < 0.01). 5. ETI: Increased by 8 msec (P > 0.05).
Circulation, Volume XL, September 1969 6. PEP: Decreased by 21 msec (P > 0.05). 7. PEPI: Decreased by 9 msec (P >0.05). 8. ET/PEP: Decreased by 0.07 (P > 0.05). The patients with ischemic heart disease, had statistically significant increase in the HR, an insignificant increase in the ETI, significant decreases in the QS2 and ET, and an insignificant decrease in the QS21, PEP, PEPI, and ET/ PEP.
Comparison of the Two Groups (Figs. 1 and 2)
The Control Period There were no significant differences in any of the parameters between the two groups before inhalation of amyl nitrite. 2. QS2: No significant difference between the two groups.
3. QS2I: No significant difference in the groups except for the 30-sec period (P < 0.05).
ET:
More decrease in the IHD group at 30 sec after inhalation than in control group (P<0.01). 5 . ETI: Less increase in the IHD group at the 15-sec and 30-sec periods (P < 0.01). 6 . PEP: Less decrease in the IHD group at the 30-sec period (P < 0.01). 7. PEPI: Less decrease in the IHD group at the 15-sec and 30-sec periods (P < 0.01). 8 . ET/PEP: Insignificantly changed in the IHD group, whereas markedly increased in the normal group at 30-sec and 45-sec intervals (P < 0.01).
Although, at the maximal effect of the drug, there were no significant differences in the changes of the HR and QS2, the different responses of ET, ETI, PEP, PEPI, and ET/PEP in the two groups were statistically significant at the level of 0.01.
Results Obtained in Japanl6
Significant differences between the normal and IHD groups were observed in the ET, ETI, PEP, PEPI, and ET/PEP at the maximal effect of amyl nitrite (table 3) . No significant differences were found in these parameters in the control period. The effects of amyl nitrite on the HR and both systolic and diastolic blood pressure were the same in the two groups. The responses of the diastolic blood pressure are shown in figure 3 .
Discussion The present study revealed that at the period of maximal effect of amyl nitrite, the normal individuals showed (1) a significant rise in the ETI and ET/PEP, (2) fall in PEP and PEPI, and (3) no significant change in the ET. The IHD group, on the contrary, demonstrated (1) a marked shortening of the ET, and (2) no significant changes in the ETI, PEP, PEPI, or ET/PEP. The increase in the heart rate and fall in the blood pressure were equally significant in the two groups.
The hemodynamic basis for the changes in the systolic time intervals induced by amyl nitrite in the normal subjects may be inferred from previous studies.7 [17] [18] [19] [20] It is well established that amyl nitrite causes sudden systemic vasodilatation resulting in a pronounced fall in BP and marked tachycardia. Cardiac output increases significantly while stroke volume (SV) increases irregularly. In the present study, the change in the ET in the normal group was less than expected from the change in the HR, as indicated by a significant rise in the ETI. This may be explained by a concomitant rise in SV and fall in BP, since it has been shown in normal subjects2 3 and i-n the isolated dog heart21 22 that the ET varies directly with SV and inversely with BP. On the other hand, the change in the PEP was more than expected from the change in the HR, as indicated by a significant fall in the PEPI. This may also be explained by a concomitant augmentation in SV and reduction in diastolic BP induced by amyl nitrite. The shortening of the PEP occurs largely during the isometric contraction period (ICD ) 3, 12 which is shortened in association with an Circulation, Volsme XL, September 1969 increased SV21, 23, 24 and fall in diastolic BP.12
In addition, the PEP may have been further reduced by an increased myocardial contractility which, along with tachycardia, may be induced by baroreceptor responses to a fall in diastolic BP. It has been reported that the PEP and ICP are inversely related to the rate of ventricular pressure rise or the contractile state of the myocardium3 12, 24 Although the changes in cardiac function induced by amyl nitrite have not been fully investigated in patients with IHD, the following explanations may be offered for the different responses to amyl nitrite of the IHD patients of this study.
It is unlikely that the responses of the systolic time intervals to amyl nitrite were due to diminished action of the drug on the systemic circulation in the IHD group, since the changes of the HR and diastolic BP were the same as those observed in the normal subjects. On the other hand, the results of the present studies may be entirely explained by the hypothesis of cardiac impairment in IHD patients, as it is in patients with mitral stenosis. 7 In heart failure, impaired left ventricular performance results in a prolonged PEP, shortened ET, and reduced SV.3 By analogy, when patients with IHD inhale amyl nitrite, an impairment in left ventricular performance, not evident at rest, may be brought out. If so, these patients would also be expected to develop a less than normal rise in SV or less than normal increase in myocardial contractility, or both, at the period of maximal effect of amyl nitrite, which would be responsible for their less than normal shortening of the PEPI. The postulated failure of SV to rise normally would also explain the absence in these patients of a significant lengthening of the ETI. Available hemodynamic data are presently inadequate for clarification of these possibilities. However, augmented gallop sounds, implying impaired left ventricular function, have been recorded in IHD patients after inhalation of amyl nitrite.' In relation to the use of amyl nitrite in individual patients, the percentage of IHD patients with normal responses to amyl nitrite inhalation is given in table 4 for each of the main systolic intervals. Twenty-seven to 33 per cent of the responses of IHD patients fell within two standard deviations of the normal group at the 30-sec period following inhalation of amyl nitrite.
The ratio of ejection time to pre-ejection period (ET to PEP), employed in the present study, has been used by Margolis8 to differentiate patients with coronary disease from normal individuals. In the present study, there was no significant difference in this ratio between the normal and IHD groups at rest. However, the ratio clearly separated the two groups under the circulatory stress of amyl nitrite, at a more definite level of statistical significance (P < 0.01) than reported by Margolis in resting subjects (P = 0.06).
The different response of the QS2I to amyl nitrite observed at the 30-sec period in the IHD group from that of the control group in the American study ( fig. 2 ) was not confirmed in the Japanese study (table 3) , and a decrease in the QS, interval following inhalation of amyl nitrite was equally significant in the two groups in both populations ( fig. 1 ). TIhe difference must, therefore, be considered questionable.
The similar results of the companion study performed in Japan confirm the observations of the present study in an entirely different and independently selected set of patients, thus excluding the possibility that our patients were an unusual or nonrepresentative group. Direct measurements of SV and myocardial contractility at the maximal effect of amyl nitrite, which are not available presently, however, will be needed to test our hypothesis of an impaired ventricular response to amyl nitrite in IHD patients. Further observations must also be made of the effect of amyl nitrite in the systolic time intervals of patients with other types of myocardial disease, since the results obtained in the patients of this study are in all likelihood not specific for IHD and may be anticipated with various types of ventricular impairment.
